Donald Trump gave a peculiar speech at the White House on December 17, reflecting on his actions and impact in the first year of his second term. During the 18-minute address, the President discussed a wide array of topics he focused on in the past year, including wages, employment, military strength, and efforts to address illegal immigration.
Trump proudly mentioned successful negotiations with major pharmaceutical companies like Pfizer and AstraZeneca to lower drug prices in the U.S. to levels comparable to other nations, claiming this would result in savings for many Americans. However, some viewers pointed out a possible mathematical error when Trump suggested cutting drug prices by up to 600%, which would imply companies paying customers to use their products, an impossibility as prices cannot be reduced beyond 100%.
While Trump has engaged in talks with pharmaceutical firms to reach agreements, it remains uncertain if consumers have actually benefited from these deals. Reports indicate that the terms of these agreements are confidential or still pending finalization. Critics seized the opportunity to comment on Trump’s mathematical misstep, with one person humorously stating, “A 600% price cut would mean drug companies pay you to take medicine.”
Despite mixed reactions, some defended Trump’s intent, suggesting he aimed to eliminate the markup on drugs, potentially reducing prices significantly. The speech drew a range of opinions, with some likening it to late-night infomercials, while others defended the underlying goal of lowering drug costs for the public.